Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli-Reference-Cited by-同舟云学术

Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli

Published:2018-11 Issue:11 Volume:24 Page:944-947
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Haruki Yuto^ORCID,Hagiya Hideharu^ORCID,Haruki Mai,Sugiyama Tetsuhiro

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference15 articles.

1. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock;Kumar;Crit Care Med,2006

2. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients;Ben-Ami;Clin Infect Dis,2009

3. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae;Nakai;J Infect Chemother,2016

4. Antibacterial Resistance Leadership Group. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia;Tamma;Clin Infect Dis,2015

5. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam;Peterson;Clin Microbiol Infect,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial resistance as a global public health threat: the way forward;EUREKA: Life Sciences;2024-03-29

2. Effect of Different Approaches to Antimicrobial Therapy with Cefmetazole and Meropenem on the Time to Defervescence in Non-Severe Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia;Infectious Disease Reports;2023-12-27

3. Effect of rapid cefpodoxime disk screening for early detection of third-generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae bacteremia;Journal of Pharmaceutical Health Care and Sciences;2023-12-01

4. Antimicrobial Multidrug Resistance: Clinical Implications for Infection Management in Critically Ill Patients;Microorganisms;2023-10-16

5. Prevalence, Characterization, and Antimicrobial Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Domestic Free-Range Poultry in Agogo, Ghana;Foodborne Pathogens and Disease;2023-02-01